Maria Georganaki
Uppsala, C 75185, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma.
Journal: Cancer cell
Published: June 10, 2022
Platelet-Specific PDGFB Ablation Impairs Tumor Vessel Integrity and Promotes Metastasis.
Journal: Cancer research
Published: November 08, 2019
Tumor endothelial cell up-regulation of IDO1 is an immunosuppressive feed-back mechanism that reduces the response to CD40-stimulating immunotherapy.
Journal: Oncoimmunology
Published: July 26, 2019
Vascular Targeting to Increase the Efficiency of Immune Checkpoint Blockade in Cancer.
Journal: Frontiers in immunology
Published: September 28, 2018
Region-by-region analysis of PET, MRI, and histology in en bloc-resected oligodendrogliomas reveals intra-tumoral heterogeneity.
Journal: European journal of nuclear medicine and molecular imaging
Published: June 04, 2018
Sunitinib enhances the antitumor responses of agonistic CD40-antibody by reducing MDSCs and synergistically improving endothelial activation and T-cell recruitment.
Journal: Oncotarget
Published: November 11, 2015
Elevated expression of the C-type lectin CD93 in the glioblastoma vasculature regulates cytoskeletal rearrangements that enhance vessel function and reduce host survival.
Journal: Cancer research
Published: December 17, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026